Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

B-cell restriction - an alternative piece to the puzzle.

Gershoni JM.

Hum Vaccin Immunother. 2019;15(9):2044-2049. doi: 10.1080/21645515.2019.1600989. Epub 2019 Apr 23.

2.

Phage display peptide libraries: deviations from randomness and correctives.

Ryvkin A, Ashkenazy H, Weiss-Ottolenghi Y, Piller C, Pupko T, Gershoni JM.

Nucleic Acids Res. 2018 May 18;46(9):e52. doi: 10.1093/nar/gky077.

3.

Unique binding modes for the broad neutralizing activity of single-chain variable fragments (scFv) targeting CD4-induced epitopes.

Tanaka K, Kuwata T, Alam M, Kaplan G, Takahama S, Valdez KPR, Roitburd-Berman A, Gershoni JM, Matsushita S.

Retrovirology. 2017 Sep 22;14(1):44. doi: 10.1186/s12977-017-0369-y.

4.

Streptococcus pneumoniae Cell-Wall-Localized Phosphoenolpyruvate Protein Phosphotransferase Can Function as an Adhesin: Identification of Its Host Target Molecules and Evaluation of Its Potential as a Vaccine.

Mizrachi Nebenzahl Y, Blau K, Kushnir T, Shagan M, Portnoi M, Cohen A, Azriel S, Malka I, Adawi A, Kafka D, Dotan S, Guterman G, Troib S, Fishilevich T, Gershoni JM, Braiman A, Mitchell AM, Mitchell TJ, Porat N, Goliand I, Chalifa Caspi V, Swiatlo E, Tal M, Ellis R, Elia N, Dagan R.

PLoS One. 2016 Mar 18;11(3):e0150320. doi: 10.1371/journal.pone.0150320. eCollection 2016.

5.

Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.

Kaplan G, Roitburd-Berman A, Lewis GK, Gershoni JM.

J Virol. 2016 Apr 14;90(9):4481-4493. doi: 10.1128/JVI.03206-15. Print 2016 May.

6.

Reconstitution of the receptor-binding motif of the SARS coronavirus.

Freund NT, Roitburd-Berman A, Sui J, Marasco WA, Gershoni JM.

Protein Eng Des Sel. 2015 Dec;28(12):567-75. doi: 10.1093/protein/gzv052. Epub 2015 Oct 20.

PMID:
26487711
7.

Allosteric induction of the CD4-bound conformation of HIV-1 Gp120.

Roitburd-Berman A, Dela G, Kaplan G, Lewis GK, Gershoni JM.

Retrovirology. 2013 Dec 5;10:147. doi: 10.1186/1742-4690-10-147.

8.

Profiling the IgOme: meeting the challenge.

Weiss-Ottolenghi Y, Gershoni JM.

FEBS Lett. 2014 Jan 21;588(2):318-25. doi: 10.1016/j.febslet.2013.11.005. Epub 2013 Nov 12. Review.

9.

NADH oxidase functions as an adhesin in Streptococcus pneumoniae and elicits a protective immune response in mice.

Muchnik L, Adawi A, Ohayon A, Dotan S, Malka I, Azriel S, Shagan M, Portnoi M, Kafka D, Nahmani H, Porgador A, Gershoni JM, Morrison DA, Mitchell A, Tal M, Ellis R, Dagan R, Nebenzahl YM.

PLoS One. 2013;8(4):e61128. doi: 10.1371/journal.pone.0061128. Epub 2013 Apr 8. Erratum in: PLoS One. 2013;8(6). doi:10.1371/annotation/7fbc524a-4035-401e-8cc7-93393afc35fd. Gershoni, Johnatan M [corrected to Gershoni, Jonathan M].

10.

The use of epitope arrays in immunodiagnosis of infectious disease: hepatitis C virus, a case study.

Siman-Tov DD, Zemel R, Tur Kaspa R, Gershoni JM.

Anal Biochem. 2013 Jan 15;432(2):63-70. doi: 10.1016/j.ab.2012.09.025. Epub 2012 Sep 24.

PMID:
23017878
11.

Deep Panning: steps towards probing the IgOme.

Ryvkin A, Ashkenazy H, Smelyanski L, Kaplan G, Penn O, Weiss-Ottolenghi Y, Privman E, Ngam PB, Woodward JE, May GD, Bell C, Pupko T, Gershoni JM.

PLoS One. 2012;7(8):e41469. doi: 10.1371/journal.pone.0041469. Epub 2012 Aug 1.

12.

Site directed biotinylation of filamentous phage structural proteins.

Smelyanski L, Gershoni JM.

Virol J. 2011 Nov 1;8:495. doi: 10.1186/1743-422X-8-495.

13.

A general insert label for peptide display on chimeric filamentous bacteriophages.

Kaplan G, Gershoni JM.

Anal Biochem. 2012 Jan 1;420(1):68-72. doi: 10.1016/j.ab.2011.08.050. Epub 2011 Sep 8.

PMID:
21945353
14.

Conformational and structural features of HIV-1 gp120 underlying the dual receptor antagonism by cross-reactive neutralizing antibody m18.

Gift SK, Zentner IJ, Schön A, McFadden K, Umashankara M, Rajagopal S, Contarino M, Duffy C, Courter JR, Zhang MY, Gershoni JM, Cocklin S, Dimitrov DS, Smith AB 3rd, Freire E, Chaiken IM.

Biochemistry. 2011 Apr 12;50(14):2756-68. doi: 10.1021/bi101160r. Epub 2011 Mar 18.

15.

Phage display selection, analysis, and prediction of B cell epitopes.

Freund NT, Enshell-Seijffers D, Gershoni JM.

Curr Protoc Immunol. 2009 Aug;Chapter 9:Unit 9.8. doi: 10.1002/0471142735.im0908s86.

PMID:
19653209
16.

Unsung hero Robert C. Gallo.

Abbadessa G, Accolla R, Aiuti F, Albini A, Aldovini A, Alfano M, Antonelli G, Bartholomew C, Bentwich Z, Bertazzoni U, Berzofsky JA, Biberfeld P, Boeri E, Buonaguro L, Buonaguro FM, Bukrinsky M, Burny A, Caruso A, Cassol S, Chandra P, Ceccherini-Nelli L, Chieco-Bianchi L, Clerici M, Colombini-Hatch S, de Giuli Morghen C, de Maria A, de Rossi A, Dierich M, Della-Favera R, Dolei A, Douek D, Erfle V, Felber B, Fiorentini S, Franchini G, Gershoni JM, Gotch F, Green P, Greene WC, Hall W, Haseltine W, Jacobson S, Kallings LO, Kalyanaraman VS, Katinger H, Khalili K, Klein G, Klein E, Klotman M, Klotman P, Kotler M, Kurth R, Lafeuillade A, La Placa M, Lewis J, Lillo F, Lisziewicz J, Lomonico A, Lopalco L, Lori F, Lusso P, Macchi B, Malim M, Margolis L, Markham PD, McClure M, Miller N, Mingari MC, Moretta L, Noonan D, O'Brien S, Okamoto T, Pal R, Palese P, Panet A, Pantaleo G, Pavlakis G, Pistello M, Plotkin S, Poli G, Pomerantz R, Radaelli A, Robertguroff M, Roederer M, Sarngadharan MG, Schols D, Secchiero P, Shearer G, Siccardi A, Stevenson M, Svoboda J, Tartaglia J, Torelli G, Tornesello ML, Tschachler E, Vaccarezza M, Vallbracht A, van Lunzen J, Varnier O, Vicenzi E, von Melchner H, Witz I, Zagury D, Zagury JF, Zauli G, Zipeto D.

Science. 2009 Jan 9;323(5911):206-7. doi: 10.1126/science.323.5911.206. No abstract available.

PMID:
19131607
17.

Molecular decoys: antidotes, therapeutics and immunomodulators.

Gershoni JM.

Curr Opin Biotechnol. 2008 Dec;19(6):644-51. doi: 10.1016/j.copbio.2008.10.001. Epub 2008 Nov 18. Review.

PMID:
18977299
18.

Label-free and dynamic detection of biomolecular interactions for high-throughput microarray applications.

Ozkumur E, Needham JW, Bergstein DA, Gonzalez R, Cabodi M, Gershoni JM, Goldberg BB, Unlü MS.

Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):7988-92. doi: 10.1073/pnas.0711421105. Epub 2008 Jun 3.

19.

Phage display selection and analysis of Ab-binding epitopes.

Enshell-Seijffers D, Gershoni JM.

Curr Protoc Immunol. 2002 Nov;Chapter 9:Unit 9.8. doi: 10.1002/0471142735.im0908s50.

PMID:
18432894
20.

Resonant Cavity Imaging: A Means Toward High-Throughput Label-Free Protein Detection.

Bergstein DA, Ozkumur E, Wu AC, Yalçin A, Colson JR, Needham JW, Irani RJ, Gershoni JM, Goldberg BB, Delisi C, Ruane MF, Unlü MS.

IEEE J Sel Top Quantum Electron. 2008;14(1):131-139.

21.

Computational characterization of B-cell epitopes.

Rubinstein ND, Mayrose I, Halperin D, Yekutieli D, Gershoni JM, Pupko T.

Mol Immunol. 2008 Jul;45(12):3477-89. Epub 2007 Nov 26.

PMID:
18023478
22.

Pepitope: epitope mapping from affinity-selected peptides.

Mayrose I, Penn O, Erez E, Rubinstein ND, Shlomi T, Freund NT, Bublil EM, Ruppin E, Sharan R, Gershoni JM, Martz E, Pupko T.

Bioinformatics. 2007 Dec 1;23(23):3244-6. Epub 2007 Oct 31.

PMID:
17977889
23.

Epitope mapping: the first step in developing epitope-based vaccines.

Gershoni JM, Roitburd-Berman A, Siman-Tov DD, Tarnovitski Freund N, Weiss Y.

BioDrugs. 2007;21(3):145-56. Review.

PMID:
17516710
24.

Flamingo cadherin: a putative host receptor for Streptococcus pneumoniae.

Blau K, Portnoi M, Shagan M, Kaganovich A, Rom S, Kafka D, Chalifa Caspi V, Porgador A, Givon-Lavi N, Gershoni JM, Dagan R, Mizrachi Nebenzahl Y.

J Infect Dis. 2007 Jun 15;195(12):1828-37. Epub 2007 May 3.

PMID:
17492599
25.

A peptide mimetic of the mycobacterial mannosylated lipoarabinomannan: characterization and potential applications.

Barenholz A, Hovav AH, Fishman Y, Rahav G, Gershoni JM, Bercovier H.

J Med Microbiol. 2007 May;56(Pt 5):579-86.

PMID:
17446277
26.

Stepwise prediction of conformational discontinuous B-cell epitopes using the Mapitope algorithm.

Bublil EM, Freund NT, Mayrose I, Penn O, Roitburd-Berman A, Rubinstein ND, Pupko T, Gershoni JM.

Proteins. 2007 Jul 1;68(1):294-304.

PMID:
17427229
27.

Epitope mapping using combinatorial phage-display libraries: a graph-based algorithm.

Mayrose I, Shlomi T, Rubinstein ND, Gershoni JM, Ruppin E, Sharan R, Pupko T.

Nucleic Acids Res. 2007;35(1):69-78. Epub 2006 Dec 6.

28.

Computational prediction of the cross-reactive neutralizing epitope corresponding to the [corrected] monclonal [corrected] antibody b12 specific for HIV-1 gp120.

Bublil EM, Yeger-Azuz S, Gershoni JM.

FASEB J. 2006 Sep;20(11):1762-74. Erratum in: FASEB J. 2006 Nov;20(13):2426.

PMID:
16940148
29.

Mapping a neutralizing epitope on the SARS coronavirus spike protein: computational prediction based on affinity-selected peptides.

Tarnovitski N, Matthews LJ, Sui J, Gershoni JM, Marasco WA.

J Mol Biol. 2006 May 26;359(1):190-201. Epub 2006 Mar 22.

PMID:
16630634
30.

Mapping and molecular characterization of novel monoclonal antibodies to conformational epitopes on NH2 and COOH termini of mammalian tryptophanyl-tRNA synthetase reveal link of the epitopes to aggregation and Alzheimer's disease.

Paley EL, Smelyanski L, Malinovskii V, Subbarayan PR, Berdichevsky Y, Posternak N, Gershoni JM, Sokolova O, Denisova G.

Mol Immunol. 2007 Jan;44(4):541-57. Epub 2006 Apr 17.

PMID:
16616781
31.

Differentiation of a passive vaccine and the humoral immune response toward infection: analysis of phage displayed peptides.

Siman-Tov DD, Navon-Perry L, Haigwood NL, Gershoni JM.

Vaccine. 2006 Jan 30;24(5):607-12. Epub 2005 Aug 24.

PMID:
16171907
32.

HIV-1 neutralization by chimeric CD4-CG10 polypeptides fused to human IgG1.

Meyuhas R, Noy H, Montefiori DC, Denisova G, Gershoni JM, Gross G.

Mol Immunol. 2005 May;42(9):1099-109. Epub 2004 Dec 21.

PMID:
15829299
33.

The mapping and reconstitution of a conformational discontinuous B-cell epitope of HIV-1.

Enshell-Seijffers D, Denisov D, Groisman B, Smelyanski L, Meyuhas R, Gross G, Denisova G, Gershoni JM.

J Mol Biol. 2003 Nov 14;334(1):87-101.

PMID:
14596802
34.

Characterization of new monoclonal antibodies that discriminate between soluble and membrane CD4 and compete with human anti-CD4 autoimmune sera.

Denisova G, Lideman L, Spectorman E, Abulafia-Lapid R, Burke M, Yust I, Gershoni JM.

Mol Immunol. 2003 Sep;40(5):231-9.

PMID:
12943795
35.

Identification of an essential component of the elicitation active site of the EIX protein elicitor.

Rotblat B, Enshell-Seijffers D, Gershoni JM, Schuster S, Avni A.

Plant J. 2002 Dec;32(6):1049-55.

36.

Dissection of the humoral immune response toward an immunodominant epitope of HIV: a model for the analysis of antibody diversity in HIV+ individuals.

Enshell-Seijffers D, Smelyanski L, Vardinon N, Yust I, Gershoni JM.

FASEB J. 2001 Oct;15(12):2112-20.

PMID:
11641237
37.

[CCR5--the HIV co-receptor--now in Israel].

Kantor R, Gershoni JM.

Harefuah. 1999 Nov 1;137(9):405-9. Review. Hebrew. No abstract available.

PMID:
11419046
38.

The rational design of a 'type 88' genetically stable peptide display vector in the filamentous bacteriophage fd.

Enshell-Seijffers D, Smelyanski L, Gershoni JM.

Nucleic Acids Res. 2001 May 15;29(10):E50-0.

39.

Use of human CD4 transgenic mice for studying immunogenicity of HIV-1 envelope protein gp120.

Seagal J, Spectorman E, Gershoni JM, Denisova GF.

Transgenic Res. 2001 Apr;10(2):113-20.

PMID:
11305358
40.

Expansion of epitope cross-reactivity by anti-idiotype modulation of the primary humoral response.

Denisova GF, Zerwanitzer M, Denisov DA, Spectorman E, Mondor I, Sattentau Q, Gershoni JM.

Mol Immunol. 2000 Jan-Feb;37(1-2):53-8.

PMID:
10781835
41.

Prevalence of a CCR5 gene 32-bp deletion in an Israeli cohort of HIV-1-infected and uninfected hemophilia patients.

Kantor R, Barzilai A, Varon D, Martinowitz U, Gershoni JM.

J Hum Virol. 1998 May-Jun;1(4):299-301.

PMID:
10195255
42.

Distribution of the CCR5 gene 32-base pair deletion in Israeli ethnic groups.

Kantor R, Gershoni JM.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Jan 1;20(1):81-4.

PMID:
9928734
43.

Construction and use of a 20-mer phage display epitope library.

Stern B, Gershoni JM.

Methods Mol Biol. 1998;87:137-54. No abstract available.

PMID:
9523268
44.

Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody.

Lee S, Peden K, Dimitrov DS, Broder CC, Manischewitz J, Denisova G, Gershoni JM, Golding H.

J Virol. 1997 Aug;71(8):6037-43.

45.

Combinatorial libraries, epitope structure and the prediction of protein conformations.

Gershoni JM, Stern B, Denisova G.

Immunol Today. 1997 Mar;18(3):108-10. Review. No abstract available.

PMID:
9078681
46.

Helical epitopes determined by low-stringency antibody screening of a combinatorial peptide library.

Stern B, Denisova G, Buyaner D, Raviv D, Gershoni JM.

FASEB J. 1997 Feb;11(2):147-53.

PMID:
9039957
47.

Conformational transitions in CD4 due to complexation with HIV envelope glycoprotein gp120.

Denisova G, Raviv D, Mondor I, Sattentau QJ, Gershoni JM.

J Immunol. 1997 Feb 1;158(3):1157-64.

PMID:
9013955
48.

Humoral immune response to immunocomplexed HIV envelope glycoprotein 120.

Denisova G, Stern B, Raviv D, Zwickel J, Smorodinsky NI, Gershoni JM.

AIDS Res Hum Retroviruses. 1996 Jul 1;12(10):901-9.

PMID:
8798975
49.

Nuclear magnetic resonance (NMR) analysis of ligand receptor interactions: the cholinergic system--a model.

Fraenkel Y, Shalev DE, Gershoni JM, Navon G.

Crit Rev Biochem Mol Biol. 1996;31(4):273-301. Review.

PMID:
8877268
50.

Complexed HIV envelope as a target for an AIDS vaccine.

Gershoni JM, Denisova GF, Raviv D, Stern B, Zwickel J.

Adv Exp Med Biol. 1996;397:91-6. No abstract available.

PMID:
8718587

Supplemental Content

Loading ...
Support Center